Health Care Equipment & Supplies · Nasdaq

DXCMDexcom Inc

Last close
$83.33 +2.4%
52-week range
$56.72 to $92.59
Market cap
$31.1B
Next earnings
Not scheduled

Fiscal 2025 at a glance

Revenue
$4.66B
+16% vs FY24
Net income
$836M
+45% vs FY24
Free cash flow
$1.08B
+71% vs FY24
Net cash
$918M
Cash $918M, no debt reported

Stock price

+413% since Dec 2016

Valuation vs its own 10 years

Below its 10-year median on all 4 multiples

Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.

P/E, trailing
32.8x
26.7x304x
10th percentile, below its median of 96.0x
Positive-earnings quarters only
Price / sales
6.1x
5.1x25.4x
10th percentile, below its median of 11.7x
EV / EBITDA
20.1x
17.9x819x
7th percentile, below its median of 76.4x
Price / free cash flow
28.3x
17.3x10,105x
11th percentile, below its median of 155x

Key statistics

Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.

Valuation

P/E
32.8x
Earnings yield
3.0%
Price / sales
6.1x
Price / book
12.3x
Price / operating cash flow
22.0x
EV / EBITDA
20.1x
EV / sales
5.9x
Free cash flow yield
3.5%

Profitability

Gross margin
63.4%
Operating margin
24.0%
Net margin
19.4%
Return on equity
39.1%
Return on capital
37.9%

Growth per year

Revenue, 3 years
+17.0%
Revenue, 5 years
+19.3%
Revenue, 9 years
+26.2%
EPS, 3 years
+36.6%

Balance sheet

Cash and investments
$961M
Total debt
n/a
Net cash
$961M
Debt / equity
n/a
Current ratio
1.74x

n/a: No debt reported

Shares and dividend

Shares outstanding
373M
Share count, 5 years
-3.5%
Beta, 1 year
0.69
Dividend yield
n/a
Dividend per share, TTM
n/a
Payout ratio
n/a

n/a: No dividend

Ten years of the business

Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.

Revenue and net incomeLatest quarter $1.34B
RevenueNet income
Gross profitLatest quarter $864M
EBITDALatest quarter $402M
Margins64 / 24 / 20%
GrossOperatingNet
Earnings per shareLatest quarter $0.72
Cash flowLatest quarter $326M
OperatingCapexFree
Cash vs debtLatest quarter $961M
Cash and investmentsTotal debt
P/E historyNow 32.8x
P/E, median 96.0x dashed
P/S historyNow 6.1x
P/S, median 11.7x dashed

Where the revenue comes from

Non Us went from 26% to 28% of revenue in 3 years

Share of revenue by region, fiscal 2022 to 2025, as reported in the 10-K.

USNon Us
FY22
74%26%
$2.91B
FY23
72%28%
$3.62B
FY24
72%28%
$4.03B
FY25
72%28%
$4.66B
Fiscal 2025 by region
RegionRevenueSharevs FY24
US$3.33B71.5%+15%
Non Us$1.33B28.5%+16%

Health Care Equipment & Supplies peers

The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.

CompanyMarket capRevenue growth Operating marginP/EP/SP/E vs own history
ABT Abbott Laboratories $188B +10% 13.8%40.4x3.9x 60th percentile
DHR Danaher Corp $164B +6% 20.4%38.1x6.4x 65th percentile
ISRG Intuitive Surgical Inc $154B +20% 28.4%53.7x13.3x 48th percentile
MDT Medtronic plc $132B +10% 18.1%25.3x3.5x 20th percentile
SYK Stryker Corp $118B +8% 20.7%33.0x4.5x 30th percentile
DXCM Dexcom Inc $31.1B +13% 24.0%32.8x6.1x 10th percentile

The company

Sector
Health Care
Industry
Health Care Equipment & Supplies
Founded
1999
Headquarters
San Diego, CA
Fiscal year ends
December
Website
dexcom.com

What it does

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.

Description from Wikipedia (CC BY-SA).

Around the numbers

What the rest of EdgeStacker knows about DXCM.

Next report

No confirmed report date in the next 95 days yet.

Open the Earnings Hub
Big funds, latest 13F

Held by 669 active funds. Crowd level: quiet.

Open the Smart money tab